WNT4 and hyperandrogenism: Moreover, some patients with MRKH and hyperandrogenism lacked mutations in WNT4, suggesting that other components of the WNT pathway might be altered or that other pathways might be responsible (Philibert et al., 2011; Chang et al., 2012).